findmyKOL
Clinical trialNCT06195709RecruitingPhase 3Interventional

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

SponsorInstitut CurieEnrollment300Breast Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Centre Hospitalier de la Côte Basque

    Bayonne, France

    Not, yet, recruiting
  • Institut Bergonié

    Bordeaux, France

    Not, yet, recruiting
  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, France

    Not, yet, recruiting
  • Centre Francois Baclesse

    Caen, France

    Recruiting
  • Centre Georges Francois Leclerc

    Dijon, France

    Recruiting
  • Centre Oscar Lambret

    Lille, France

    Recruiting
  • Chu Limoges

    Limoges, France

    Not, yet, recruiting
  • Centre Leon Bérard

    Lyon, France

    Not, yet, recruiting
  • Institut Paoli-Calmettes

    Marseille, France

    Recruiting
  • Institut Du Cancer Montpellier

    Montpellier, France

    Recruiting
  • Centre Antoine Lacassagne

    Nice, France

    Recruiting
  • Hôpital Universitaire de Nimes

    Nîmes, France

    Not, yet, recruiting
  • Institut Curie

    Paris, France

    Recruiting
  • Centre Eugène Marquis

    Rennes, France

    Recruiting
  • Centre Henri Becquerel

    Rouen, France

    Not, yet, recruiting
  • Institut Curie

    Saint-Cloud, France

    Recruiting
  • Bruno Maucherat

    Saint-Herblain, France

    Withdrawn
  • Centre de Lutte Contre Le Cancer Paul Strauss

    Strasbourg, France

    Not, yet, recruiting
  • Oncopole Claudius Regaud

    Toulouse, France

    Not, yet, recruiting
  • Hôpital Bretonneau-Chu Tours

    Tours, France

    Not, yet, recruiting
  • Institut de Cancerologie de Lorraine

    Vandœuvre-lès-Nancy, France

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 May 2024
Primary completion
27 Sept 2029
Completion
27 Sept 2030
Last update posted
17 Apr 2026
Registered enrollment
300
Registry id
NCT06195709

Cross-registrations

EU-CTR / CTIS (EudraCT)2023-506282-66-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.